LEADER 03377oam  2200385z- 450 
001 9910795921903321
005 20210114221749.0
010   $a0-309-45511-1
010   $a0-309-45509-X
035   $a(CKB)3710000001417518
035   $a(MiAaPQ)EBC4886654
035   $a(EXLCZ)993710000001417518
100   $a20181028c2017uuuu  -u-            -
101 0 $aeng
200 10$aExploring the state of the science in the field of regenerative medicine $echallenges of and opportunities for cellular therapies : proceedings of a workshop /$fAriel Markowitz-Shulman, Erin Hammers-Forstag, Siobhan Addie, and Sarah H. Beachy, rapporteurs ; Forum on Regenerative Medicine, Board on Health Sciences Policy, Health and Medicine Division, the National Academies of Sciences, Engineering, Medicine
210   $aWashington, D.C$cNational Academies Press
311   $a0-309-45508-1 
327   $aIntroduction -- Skin and musculoskeletal tissues -- Hematologic and immunologic applications -- Neurological and ophthalmological tissues -- Cardiovascular and lung tissues -- Renal tissue -- Looking toward the future: concluding thoughts -- References -- Appendix A: Workshop agenda -- Appendix B: Speaker biographical sketches -- Appendix C: Statement of task -- Appendix D: Registered attendees.
330 1 $a"Regenerative medicine holds the potential to create living, functional cells and tissues that can be used to repair or replace those that have suffered potentially irreparable damage due to disease, age, traumatic injury, or genetic and congenital defects. The field of regenerative medicine is broad and includes research and development components of gene and cell therapies, tissue engineering, and non-biologic constructs. Although regenerative medicine has the potential to improve health and deliver economic benefits, this relatively new field faces challenges to developing policies and procedures to support the development of novel therapies are both safe and effective. In October 2016, the National Academies of Sciences, Engineering, and Medicine hosted a public workshop with the goal of developing a broad understanding of the opportunities and challenges associated with regenerative medicine cellular therapies and related technologies. Participants explored the state of the science of cell-based regenerative therapies within the larger context of patient care and policy. This publication summarizes the presentations and discussions from the workshop"--Publisher's description.
606   $aRegenerative medicine$vCongresses
606   $aRegenerative medicine$2fast$3(OCoLC)fst01745494
608   $aConference papers and proceedings.$2fast
615  0$aRegenerative medicine
615  7$aRegenerative medicine.
676   $a571.8/89
700   $aMarkowitz-Shulman$b Ariel$01528417
702   $aForstag$b Erin Hammers
702   $aAddie$b Siobhan
702   $aBeachy$b Sarah H.
712 02$aNational Academies of Sciences, Engineering, and Medicine (U.S.).$bForum on Regenerative Medicine,
712 12$aState of the Science in the Field of Regenerative Medicine: Challenges of and Opportunities for Cellular Therapies: a Workshop$f(2016 :$eWashington, D.C.),$bauthor.
906   $aBOOK
912   $a9910795921903321
996   $aExploring the state of the science in the field of regenerative medicine$93771982
997   $aUNINA